New vaccine introduction pentavalent vaccine india_b_ankura

drdduttaM 9,048 views 15 slides Feb 01, 2016
Slide 1
Slide 1 of 15
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15

About This Presentation

UNDERSTANDING OF New vaccine introduction pentavalent vaccine


Slide Content

New Vaccine Introduction- Pentavalent

One vaccine against Five diseases (DPT+ Hepatitis B +HiB) Diphtheria Pertussis Tetanus Hepatitis B Haemophilus Influenza B (HiB)

What is Hib ? What diseases does it cause? Hib is the abbreviation for Haemophilus influenzae type b , a gram negetive encapsulated cocco bacilus that causes severe infections, as listed below.  Bacterial meningitis – inflammation of the membranes that cover and protect the spinal cord and brain. It is a serious infection.  Pneumonia – inflammation of the lungs.  Epiglottitis – inflammation of the area around the vocal cords and obstruction of the airway.  Septic arthritis – inflammation of the joints.  Septicaemia /Sepsis – presence of pathogenic bacteria in the blood. Rarely caused by HIB but always fatal

Haemophilus influenzae type b Clinical Features

Key facts about 5 th component of Pentavalent (HIB) 1. Globally, Hib kills more than 370,000 children under five every year. Nearly 20% of symptomatic children die in India. Hib disease survivors are often permanently paralysed,become deaf or get brain damaged. 2. 3 primary dose usually confer protection for more than 15 years 3. Hib vaccine can prevent over a third of pneumonia cases and 90% of Hib meningitis cases. 4 . Not a contraindication , rather specially indicated in case of Asplenia , Sickle cell anaemia , HIV & Other Immunodeficiency

Site of injection : Same as DPT or Hep B vaccine- anterolateral aspect of mid-thigh in infants Dose : 0.5 ml dose of the vaccine administered intramuscularly. Route : Injected intramuscularly (I/M) using auto disable (AD) syringe Age group : 3 doses at 6, 10 and 14 weeks. No booster dose. Formulation : It is a liquid vaccine so diluent is not required. Presentation : 10-dose vial. Storage : +2°C to +8°C in ILR; should not be frozen.

Pentavalent vaccine introduced – 8 states 178.7 lakhs (1.78 crores) children vaccinated up to April 2014. Pentavalent vaccine introduction proposed in Oct 2014 – 11 states Pentavalent vaccine introduction proposed in Apr 2015 – 16 states States Pentavalent introduction plan Oct 2014 1 Andhra Pradesh 2 Assam 3 Bihar 4 Chhattisgarh 5 Delhi 6 Jharkhand 7 Madhya Pradesh 8 Punjab 9 Rajasthan 10 Uttarakhand 11 West Bengal

Pentavalent vaccine will replace DPT 1, 2, 3 and Hep 1, 2, 3 doses . Hep B vaccine will be continued only as birth dose (within 24 hours) in case of institutional deliveries. DPT vaccine will be continued in the RI program as booster dose at 16-24 months and 5 years. Once pentavalent vaccine reaches states , then existing DPT and Hep B Vaccine stocks will need attention . Infants that have already started with DPT vaccination will continue and complete the schedule with DPT vaccine . Upper age limit in UIP is 1 year Interchangeability between licensed brands is acceptable Open vial policy will be followed with pentavalent vaccine. VVM is present on the vial . Pentavalent Vaccine : Key points to Remember  

District Hep B Wastage 2013-2014 PURULIA 29 UTTAR DINAJPUR 23.05 BANKURA 22 MURSHIDABAD 22 KOLKATA 20.87 KOCHBIHAR 20.61 HOWRAH 20.06 24-PARGANAS SOUTH 14.4 PASCHIM MEDINIPUR 13.09 NADIA 9.8 MALDA 9.4 HUGLI 1.7 24-PARGANAS NORTH 1.2 JALPAIGURI 1

Some Common Block/PU level issues which need to be addressed before launching Pentavalent Incomplete RI micro planning- leading poor defaulter tracking & vaccine wastage Implementation of Open vial policy – Not universally followed according to guideline (Time/Date not written) Repair/ Maintenance of cold chain equipment system – slow response & irregular process Lagging of MCTS updating- connectivity problem/ ANMs are not updating the service/ Knowledge Gap Lack of accountable human resource & lack of Focus in Urban area

Communication Plan preparations Sensitization meeting under chairmanship of DM involving all major Private Health facilities, Private Paediatrician & NGOs Written communication/sharing IEC if needed specially who has not been sensitized so far Orientation of media by DM & CMOH ( print, electronic, web based)…. To prevent base less rumor. Training preparations Training of all medical officers and other health personnel (BPHN/PHN, HWs, MOs, Supervisors, AYUSH) Sensitize vaccine & cold chain handlers, data handlers, frontline health workers - ASHA/ AWW.

Strengthen AEFI surveillance AEFI Committee formation AEFI management Kit for all Blocks Regular district level review meeting on RI (monthly DTFI) Micro planning preparations Existing RI microplan Very costly vaccine – so wastage should be minimized No. of session should be guided by geographical distribution of population & injection load (25-50/month for OR & 40-70/Month for SC) Good AVD Plan- Daily vaccine return is mandatory Block level Microplanning Meeting for Updating of MP ( in Standard format) By end of September - Vaccine & Logistic supply from state will be done after submission of The Checklist .

We have to prevent the effect of this type of baseless rumor

Simultaneously we have to arrange for the circulation of the correct message to the community

Thank you
Tags